1

iSpecimen

#10000

Rank

$4.13M

Marketcap

US United States

Country

iSpecimen
Leadership team

Ms. Tracy Wilson Curley (CFO, Treasurer & Interim CEO)

Dr. Christopher J. Ianelli M.D., Ph.D. (Founder & Director)

Mr. Benjamin Bielak (Chief Information Officer)

Products/ Services
Biotechnology, Life Science, Marketplace
Number of Employees
50 - 100
Headquarters
Lexington, Massachusetts, United States
Established
2012
Company Registration
SEC CIK number: 0001558569
Revenue
5M - 20M
Traded as
ISPC
Social Media
Overview
Location
Summary
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
History

Founded in 2012, iSpecimen built a comprehensive specimen and clinical data ecosystem that leverages state-of-the-art technologies in the areas of data analytics, automation, personalization, and artificial intelligence (AI). iSpecimen has created the world’s largest available specimen and clinical data marketplace with over 150 million human tissue, biofluid and human cell samples, as well as associated clinical data. From its founding, iSpecimen remained committed to its mission to promote and empower research while preserving the privacy and rights of the individual.

Mission
iSpecimen's mission is to accelerate the progress of medical research and discovery by providing industry-leading technology and services that facilitate secure, compliant and cost-effective access to human biospecimens and associated clinical data for research.
Vision
We envision a world where researchers and innovators have swift and reliable access to the human specimens and data sets they need to advance human healthcare, and where specimen contributors are treated as equal and essential participants in the advancement of medical research.
Key Team

Ms. Jill Mullan (Sec. & Director)

Ms. Dawn Michelle (VP of Operations)

Mr. David Wages M.D., Ph.D. (Chief Medical Officer)

Mr. Eric Langlois (Sr. VP of Sales & Bus. Devel.)

Ms. Carly Lejnieks (VP of Marketing)

Ms. Emily Hubbard (VP of Site Management & Devel.)

Recognition and Awards
iSpecimen has been recognized in the past as one of the 50 Most Promising New Companies in Massachusetts by the MassTLC Leadership Awards, a winner of the Connected World Awards, a three-time Red Herring Top 100 North America finalist, and a recipient of the 2016 CXO Innovation Trailblazer Award for the Best Use of Data Analytics.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

iSpecimen
Leadership team

Ms. Tracy Wilson Curley (CFO, Treasurer & Interim CEO)

Dr. Christopher J. Ianelli M.D., Ph.D. (Founder & Director)

Mr. Benjamin Bielak (Chief Information Officer)

Products/ Services
Biotechnology, Life Science, Marketplace
Number of Employees
50 - 100
Headquarters
Lexington, Massachusetts, United States
Established
2012
Company Registration
SEC CIK number: 0001558569
Revenue
5M - 20M
Traded as
ISPC
Social Media